Questions about getting your next Prolia® dose during COVID-19? Our resource center has answers. CLICK HERE.
Prolia® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.
Prolia® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture.
Prolia® is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
Prolia® is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.
Prolia® is an injection administered by a healthcare professional and is covered by bothMedicare Part B and Medicare Part D
What you pay will depend on your Medicare plan and whether your doctor orders Prolia® from a distributor (medical benefit) or gets it from a pharmacy (pharmacy benefit).
Ask your doctor how you can get Prolia®
Nearly 77% of Medicare Part B Prolia® patients have supplemental insurance‡ and pay $0§ out-of-pocket every six months
The remaining 23% of Medicare Part B Prolia® patients pay up to $212.99§,** out-of-pocket every six months depending on the patient's selected Part B plan
Patients pay for Prolia® twice per year
These data do not include out-of-pocket costs related to office visits or administration of Prolia®
63% of all Medicare Part D patients pay less than $50§,** out-of-pocket every six months
36% of all Medicare Part D patients pay $50.02-$667.29§,** out-of-pocket every six months††
Your out-of-pocket costs can vary throughout the year depending on which phase‡‡ of the Part D benefit you are currently in
If you are eligible for the Extra Help§§ program, you pay as little as $3.70 out-of-pocket every six months
Patients pay for Prolia® twice per year
These data do not include out-of-pocket costs related to office visits or administration of Prolia®
‡Supplemental insurance, also known as secondary insurance or Medigap, helps cover the remaining 20% of therapies that are provided through Medicare Part B. Medicare patients with supplemental coverage may require additional monthly premium. Individual out-of-pocket costs will vary.
§This data is based on Medicare claims between 10/2017 - 06/2018 and only applies to your cost for Prolia®.
**Patients on high deductible plans may pay more out-of-pocket for Prolia®.
††The remaining 1% will pay more out-of-pocket.
‡‡Medicare Part D drug coverage is divided into four phases, each with a different cost sharing amount. Those phases are 1) Deductible, 2) Initial coverage, 3) Coverage gap, 4) Catastrophic.
§§ Additional assistance with Medicare Prescription Drug Plan Costs from the Social Security Administration (SSA) https://www.ssa.gov/benefits/medicare/prescriptionhelp. Accessed on March 22, 2019.
59% of commercial prescriptions cost $50 or less per six months, the remaining 41% of commercial prescriptions cost an average of $437 per six months. ***
Your out-of-pocket costs may vary depending on your insurance plan. Each plan has different out-of-pocket costs, and most include an annual deductible. Patients on high deductible plans may pay more out-of-pocket for Prolia®.
And eligible commercial patients could pay $25 or less with the Prolia® Co-Pay Program for 1 shot of Prolia® up to the program maximum of $1,500 per calendar year.†††
***Based on paid claims data from national data providers for the period 1/1/2018 - 12/31/2018. These data do not include out-of-pocket costs related to office visits or administration of Prolia®. Your actual cost may vary depending on your insurance coverage and eligibility for and participation in support programs such as the Prolia® co-pay program. Talk to your insurance provider for specific information about your prescription coverage.
†††This program does not provide support for any physician-related services associated with administration of Prolia®. See eligibility and limits.
For more information about this program and eligibility requirements, call 844-369-9962 or visit proliasupport.com.
The Prolia® Co-pay Program Prepaid MasterCard® is issued by Comerica Bank pursuant to license by MasterCard International Incorporated. No cash or ATM access. MasterCard is a registered trademark of MasterCard International Incorporated. This card can be used only to cover co-payment for eligible prescriptions covered under the program at participating merchant locations where Debit MasterCard is accepted.
What are the possible side effects of Prolia®?
It is not known if the use of Prolia® over a long period of time may cause slow healing of broken bones. The most common side effects of Prolia® in women being treated for osteoporosis after menopause are back pain, pain in your arms and legs, high cholesterol, muscle pain, and bladder infection.
The most common side effects of Prolia® in men with osteoporosis are back pain, joint pain, and common cold (runny nose or sore throat).
The most common side effects of Prolia® in patients with corticosteroid-induced osteoporosis are back pain, high blood pressure, lung infection (bronchitis), and headache.
The most common side effects of Prolia® in patients receiving certain treatments for prostate or breast cancer are joint pain, back pain, pain in your arms and legs, and muscle pain. Additionally, in Prolia®-treated men with nonmetastatic prostate cancer receiving ADT, a greater incidence of cataracts was observed.
These are not all the possible side effects of Prolia®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Prolia® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.
Prolia® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.
Prolia® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture.
Prolia® is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
Prolia® is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.
Please see Prolia® full Prescribing Information and Medication Guide.